Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
880
NCT03230786
Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 23, 2017
Completion: Jul 31, 2018
NCT03907202
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Phase: Phase 1
Start: Apr 17, 2018
Completion: Dec 3, 2019
NCT06833749
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
Start: Jan 28, 2025
Completion: Dec 31, 2026